Last Updated : May 10, 2011
Details
FilesGeneric Name:
Fingolimod
Project Status:
Complete
Therapeutic Area:
Multiple Sclerosis, relapsing-remitting
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Gilenya
Project Line:
Reimbursement Review
Project Number:
SR0228-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Multiple Sclerosis
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : May 10, 2011